Inhibition of japanese encephalitis virus infection by flavivirus recombinant e protein domain III

Jingjing Fan, Yi Liu, Xuping Xie, Bo Zhang, Zhiming Yuan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus closely related to the human pathogens including yellow fever virus, dengue virus and West Nile virus. There are currently no effective antiviral therapies for all of the flavivirus and only a few highly effective vaccines are licensed for human use. In this paper, the E protein domain III (DIII) of six heterologous flaviviruses (DENV1-4, WNV and JEV) was expressed in Escherichia coli successfully. The proteins were purified after a solubilization and refolding procedure, characterized by SDS-PAGE and Western blotting. Competitive inhibition showed that all recombinant flavivirus DIII proteins blocked the entry of JEV into BHK-21 cells. Further studies indicated that antibodies induced by the soluble recombinant flavivirus DIII partially protected mice against lethal JEV challenge. These results demonstrated that recombinant flavivirus DIII proteins could inhibit JEV infection competitively, and immunization with proper folding flavivirus DIII induced cross-protection against JEV infection in mice, implying a possible role of DIII for the cross-protection among flavivirus as well as its use in antigens for immunization in animal models.

Original languageEnglish (US)
Pages (from-to)152-160
Number of pages9
JournalVirologica Sinica
Volume28
Issue number3
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Japanese Encephalitis Virus
Flavivirus Infections
Flavivirus
Recombinant Proteins
Cross Protection
Immunization
Yellow fever virus
West Nile virus
Dengue Virus
Protein Domains
Infection
Culicidae
Antiviral Agents
Polyacrylamide Gel Electrophoresis
Vaccines
Animal Models
Western Blotting

Keywords

  • Antibody
  • Cross-protection
  • E protein domain III
  • Japanese encephalitis virus

ASJC Scopus subject areas

  • Virology
  • Molecular Medicine
  • Immunology

Cite this

Inhibition of japanese encephalitis virus infection by flavivirus recombinant e protein domain III. / Fan, Jingjing; Liu, Yi; Xie, Xuping; Zhang, Bo; Yuan, Zhiming.

In: Virologica Sinica, Vol. 28, No. 3, 06.2013, p. 152-160.

Research output: Contribution to journalArticle

Fan, Jingjing ; Liu, Yi ; Xie, Xuping ; Zhang, Bo ; Yuan, Zhiming. / Inhibition of japanese encephalitis virus infection by flavivirus recombinant e protein domain III. In: Virologica Sinica. 2013 ; Vol. 28, No. 3. pp. 152-160.
@article{ed27f2831a3e428c8745f6cca213399d,
title = "Inhibition of japanese encephalitis virus infection by flavivirus recombinant e protein domain III",
abstract = "Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus closely related to the human pathogens including yellow fever virus, dengue virus and West Nile virus. There are currently no effective antiviral therapies for all of the flavivirus and only a few highly effective vaccines are licensed for human use. In this paper, the E protein domain III (DIII) of six heterologous flaviviruses (DENV1-4, WNV and JEV) was expressed in Escherichia coli successfully. The proteins were purified after a solubilization and refolding procedure, characterized by SDS-PAGE and Western blotting. Competitive inhibition showed that all recombinant flavivirus DIII proteins blocked the entry of JEV into BHK-21 cells. Further studies indicated that antibodies induced by the soluble recombinant flavivirus DIII partially protected mice against lethal JEV challenge. These results demonstrated that recombinant flavivirus DIII proteins could inhibit JEV infection competitively, and immunization with proper folding flavivirus DIII induced cross-protection against JEV infection in mice, implying a possible role of DIII for the cross-protection among flavivirus as well as its use in antigens for immunization in animal models.",
keywords = "Antibody, Cross-protection, E protein domain III, Japanese encephalitis virus",
author = "Jingjing Fan and Yi Liu and Xuping Xie and Bo Zhang and Zhiming Yuan",
year = "2013",
month = "6",
doi = "10.1007/s12250-013-3331-8",
language = "English (US)",
volume = "28",
pages = "152--160",
journal = "Virologica Sinica",
issn = "1674-0769",
publisher = "Ko hsueh chu pan she",
number = "3",

}

TY - JOUR

T1 - Inhibition of japanese encephalitis virus infection by flavivirus recombinant e protein domain III

AU - Fan, Jingjing

AU - Liu, Yi

AU - Xie, Xuping

AU - Zhang, Bo

AU - Yuan, Zhiming

PY - 2013/6

Y1 - 2013/6

N2 - Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus closely related to the human pathogens including yellow fever virus, dengue virus and West Nile virus. There are currently no effective antiviral therapies for all of the flavivirus and only a few highly effective vaccines are licensed for human use. In this paper, the E protein domain III (DIII) of six heterologous flaviviruses (DENV1-4, WNV and JEV) was expressed in Escherichia coli successfully. The proteins were purified after a solubilization and refolding procedure, characterized by SDS-PAGE and Western blotting. Competitive inhibition showed that all recombinant flavivirus DIII proteins blocked the entry of JEV into BHK-21 cells. Further studies indicated that antibodies induced by the soluble recombinant flavivirus DIII partially protected mice against lethal JEV challenge. These results demonstrated that recombinant flavivirus DIII proteins could inhibit JEV infection competitively, and immunization with proper folding flavivirus DIII induced cross-protection against JEV infection in mice, implying a possible role of DIII for the cross-protection among flavivirus as well as its use in antigens for immunization in animal models.

AB - Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus closely related to the human pathogens including yellow fever virus, dengue virus and West Nile virus. There are currently no effective antiviral therapies for all of the flavivirus and only a few highly effective vaccines are licensed for human use. In this paper, the E protein domain III (DIII) of six heterologous flaviviruses (DENV1-4, WNV and JEV) was expressed in Escherichia coli successfully. The proteins were purified after a solubilization and refolding procedure, characterized by SDS-PAGE and Western blotting. Competitive inhibition showed that all recombinant flavivirus DIII proteins blocked the entry of JEV into BHK-21 cells. Further studies indicated that antibodies induced by the soluble recombinant flavivirus DIII partially protected mice against lethal JEV challenge. These results demonstrated that recombinant flavivirus DIII proteins could inhibit JEV infection competitively, and immunization with proper folding flavivirus DIII induced cross-protection against JEV infection in mice, implying a possible role of DIII for the cross-protection among flavivirus as well as its use in antigens for immunization in animal models.

KW - Antibody

KW - Cross-protection

KW - E protein domain III

KW - Japanese encephalitis virus

UR - http://www.scopus.com/inward/record.url?scp=84879239520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879239520&partnerID=8YFLogxK

U2 - 10.1007/s12250-013-3331-8

DO - 10.1007/s12250-013-3331-8

M3 - Article

VL - 28

SP - 152

EP - 160

JO - Virologica Sinica

JF - Virologica Sinica

SN - 1674-0769

IS - 3

ER -